NCT05446922

Brief Summary

BrainTale has developed a standardization approach based on averaging measurements in predefined brain regions of interest and use of reference data acquired from healthy volunteers under conditions (MRI machine, acquisition protocol) identical to those used for the examination of the patient. The present study is intended to support the normalization step on healthy volunteers in clinical centres that will be equipped with the BrainTale medical device software dedicated to clinical routine practice and to assess, through a multicentre study, the impact of this normalization step on the variability of the MRI diffusion parameters. The data collected will support characterization and modelisation of the variability to explore further biais corrections methods. The study will be conducted by neuroradiologists of the neuroradiology departments of five clinical centres in France.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 15, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 7, 2022

Completed
1.2 years until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

August 1, 2023

Status Verified

July 1, 2023

Enrollment Period

6 months

First QC Date

June 15, 2022

Last Update Submit

July 31, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Coefficients of Variation (%CV) of FA measurement

    Percentage Coefficients of Variation (%CV) of FA measurements obtained from QC-passed DTI sequences before and after application of the normalization process.

    Day 1

Secondary Outcomes (3)

  • Coefficients of Variation (%CV) of MD measurement

    Day 1

  • Coefficients of Variation (%CV) of AD measurement

    Day 1

  • Coefficients of Variation (%CV) of RD measurement

    Day 1

Other Outcomes (3)

  • Intraclass Correlation Coefficient (ICC)

    Day 1

  • percentage Coefficient of Variation (%CV) of the Neurite Orientation Dispersion and Density Imaging (NODDI) multishell diffusion scalar parameters.

    Day 1

  • percentage Coefficient of Variation (%CV) of the resting-state functional MRI (fMRI) parameters.

    Day 1

Study Arms (1)

MRI imaging of 10 healthy volunteers

OTHER

10 healthy volunteers will proceed at an brain MRI imaging

Other: Diffusion MRI

Interventions

All procedures will be performed during a single visit. Subjects will be invited to lie on the scanning bed that will be moved head first into the scanner such as the head lie under the scanner magnets. Hearing protection will be provided to each subject to muffle the noise produced by the MRI scanner. Subjects will also be provided with pillows and blankets to keep them comfortable. They will also be given a call button that they can push to stop the procedure at any time. MRI acquisition will be performed on 1.5T or 3.0T MRI scanners depending on centre's equipment. Acquisition protocol will include the following sequences with the best parameters chosen by local radiologist and technical BrainTale team.

MRI imaging of 10 healthy volunteers

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female aged 18 up to 80 years old
  • Covered by a healthcare insurance
  • Agreeing to be informed about any incidental finding discovered on brain MRI
  • Written informed consent form signed

You may not qualify if:

  • History of brain pathology, cognitive or psychiatric disorder
  • Any contraindication \* for undergoing brain MRI
  • Subject refusing to participate or having expressed refusal to data collection/processing or unable to give his/her agreement to participate
  • Vulnerable subject (i.e. pregnant or breast-feeding woman, child, subject under curatorship or deprived of liberty)
  • contraindications to MRI include: pacemaker, neural stimulator, intraocular or intracerebral device, cochlear implant, MR-incompatible prosthetic heart valves, any implant with metallic, ferromagnetic or electrically conductive parts, any metal in the body which cannot be removed, claustrophobia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Diffusion Tensor Imaging

Intervention Hierarchy (Ancestors)

NeuroimagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDiffusion Magnetic Resonance ImagingMagnetic Resonance ImagingTomographyDiagnostic Techniques, NeurologicalInvestigative Techniques

Study Officials

  • PERLBARG Vincent

    Braintale

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2022

First Posted

July 7, 2022

Study Start

September 1, 2023

Primary Completion

March 1, 2024

Study Completion

May 1, 2024

Last Updated

August 1, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share